NanoViricides Inc. (NNVC)

[frrol]

TThe HHV cream IND is being put on a back burner. They have plenty of capital and most work is supposedly done. They have reputation of not getting IND's, an inability to focus, and they do this. Not a good idea.


The PR also points out that NV CoV 1R would be for "emergency use". That is correct, it would not replace a vaccine. It would be the kind of drug that, if it works, would be kept in ERs and clinics for severe or comorbid COVID cases.

So HHV is out for at least a while. Next step should be lab testing of the CoV 1R with actual CV S2 viruses. Let's see.